Cargando…
Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate
Liquid medium cultures of three human cell lines (B-lymphoma, myeloma, and squamous lung carcinoma) with population-doubling times (PDT) and cloning efficiencies (CE) in the range of 32-43 h and 0.01-5.6%, respectively, were exposed to 5-azacytidine (5-azaC) for 3 d. The doses used (1-3 microM) were...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2113457/ https://www.ncbi.nlm.nih.gov/pubmed/2578470 |
Ejemplares similares
-
Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011) -
DNA methylation patterns of Brachypodium distachyon chromosomes and their alteration by 5-azacytidine treatment
por: Borowska, Natalia, et al.
Publicado: (2011) -
Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36
por: Poirier, Florence, et al.
Publicado: (2001) -
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming
por: Kuehl, Philip J., et al.
Publicado: (2020) -
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
por: Diamantopoulos, Panagiotis, et al.
Publicado: (2019)